Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (911-920 of 1,023) with videos related to

Pageof 103
Sort By:
American Heart Journal|April 1, 2009
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registryEric M Crespo, Gustavo B F Oliveira, Emily F Honeycutt, et al.
JAMA|August 27, 2009
Sex differences in mortality following acute coronary syndromesJeffrey S Berger, Laine Elliott, Dianne Gallup, et al.
American Heart Journal|May 20, 2026
Predictors of ischemic stroke and major bleeding among patients with atrial fibrillation in clinical practicePishoy Gouda, Josephine Harrington, Kelly Arps, et al.
Circulation. Cardiovascular Interventions|January 14, 2017
Association of Rapid Care Process Implementation on Reperfusion Times Across Multiple ST-Segment-Elevation Myocardial Infarction NetworksChristopher B Fordyce, Hussein R Al-Khalidi, James G Jollis, et al.
Circulation. Cardiovascular Quality and Outcomes|June 27, 2020
Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment-Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 ProjectMichel Zeitouni, Hussein R Al-Khalidi, Mayme L Roettig, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Systematic adjudication of myocardial infarction end-points in an international clinical trialKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.
The New England Journal of Medicine|May 22, 2009
Early versus delayed invasive intervention in acute coronary syndromesShamir R Mehta, Christopher B Granger, William E Boden, et al.
Circulation|January 24, 2024
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial FibrillationSiddharth M Patel, Eugene Braunwald, Jan Steffel, et al.
JAMA Cardiology|November 12, 2025
Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical TrialDeborah M Siegal, Christian Sticherling, Jeff S Healey, et al.
Pageof 103

Showing results (911-920 of 1,023) with videos related to

Sort By:
Pageof 103
American Heart Journal|April 1, 2009
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registryEric M Crespo, Gustavo B F Oliveira, Emily F Honeycutt, et al.
JAMA|August 27, 2009
Sex differences in mortality following acute coronary syndromesJeffrey S Berger, Laine Elliott, Dianne Gallup, et al.
American Heart Journal|May 20, 2026
Predictors of ischemic stroke and major bleeding among patients with atrial fibrillation in clinical practicePishoy Gouda, Josephine Harrington, Kelly Arps, et al.
Circulation. Cardiovascular Interventions|January 14, 2017
Association of Rapid Care Process Implementation on Reperfusion Times Across Multiple ST-Segment-Elevation Myocardial Infarction NetworksChristopher B Fordyce, Hussein R Al-Khalidi, James G Jollis, et al.
Circulation. Cardiovascular Quality and Outcomes|June 27, 2020
Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment-Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 ProjectMichel Zeitouni, Hussein R Al-Khalidi, Mayme L Roettig, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Systematic adjudication of myocardial infarction end-points in an international clinical trialKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.
The New England Journal of Medicine|May 22, 2009
Early versus delayed invasive intervention in acute coronary syndromesShamir R Mehta, Christopher B Granger, William E Boden, et al.
Circulation|January 24, 2024
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial FibrillationSiddharth M Patel, Eugene Braunwald, Jan Steffel, et al.
JAMA Cardiology|November 12, 2025
Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical TrialDeborah M Siegal, Christian Sticherling, Jeff S Healey, et al.
Pageof 103